Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours Β· Estimated delivery Aug 22 - Aug 27
Not for human consumption or medical use
Key Highlights AOD9604 activates lipolytic pathways through beta-3 adrenergic receptor upregulation and cAMP-PKA-HSL cascade activation in adipocytes The peptide inhibits acetyl-CoA carboxylase to suppress lipogenesis while promoting fatty acid oxidation in laboratory models Research confirms no IGF-1 stimulation or glucose metabolism disruption, distinguishing it from full-length growth hormone Cartilage studies show proteoglycan synthesis enhancement and improved tissue structure in osteoarthritis animal models What is AOD9604
In animal models, TB-500 increased re-epithelialization rates and accelerated wound closure compared to placebo controls.- Clinical trials with thymosin beta-4 analogues showed improved outcomes in patients with chronic pressure ulcers.- BPC-157 studies demonstrated higher collagen deposition, angiogenesis, and granulation tissue formation in injured tissue models
So, the next time you place that vial back into its cool, dark spot in the refrigerator, know that you're not just following a rule
US$ 27.74
US$ 23.20
US$ 23.49
)
US$ 25.56
